ATE282205T1 - Verfahren zur detektion von prostata-spezifischem membran-antigen in serum - Google Patents

Verfahren zur detektion von prostata-spezifischem membran-antigen in serum

Info

Publication number
ATE282205T1
ATE282205T1 AT01115042T AT01115042T ATE282205T1 AT E282205 T1 ATE282205 T1 AT E282205T1 AT 01115042 T AT01115042 T AT 01115042T AT 01115042 T AT01115042 T AT 01115042T AT E282205 T1 ATE282205 T1 AT E282205T1
Authority
AT
Austria
Prior art keywords
psma
serum
antibody
detecting
captured
Prior art date
Application number
AT01115042T
Other languages
English (en)
Inventor
Elzbieta Kawinski
Kailash C Chadha
Original Assignee
Health Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/624,692 external-priority patent/US6379550B1/en
Application filed by Health Research Inc filed Critical Health Research Inc
Application granted granted Critical
Publication of ATE282205T1 publication Critical patent/ATE282205T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT01115042T 2000-07-24 2001-06-21 Verfahren zur detektion von prostata-spezifischem membran-antigen in serum ATE282205T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/624,692 US6379550B1 (en) 2000-07-24 2000-07-24 Method for detecting PSA and its molecular forms using thiophilic gel
US09/851,263 US6475389B2 (en) 2000-07-24 2001-05-08 Method for detection of prostate specific membrane antigen in serum

Publications (1)

Publication Number Publication Date
ATE282205T1 true ATE282205T1 (de) 2004-11-15

Family

ID=27089736

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01115042T ATE282205T1 (de) 2000-07-24 2001-06-21 Verfahren zur detektion von prostata-spezifischem membran-antigen in serum

Country Status (6)

Country Link
US (1) US6692643B2 (de)
EP (1) EP1178317B1 (de)
JP (1) JP2002277469A (de)
AT (1) ATE282205T1 (de)
CA (1) CA2353267A1 (de)
DE (1) DE60107022T2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050215472A1 (en) 2001-10-23 2005-09-29 Psma Development Company, Llc PSMA formulations and uses thereof
AU2002356844C1 (en) 2001-10-23 2010-03-04 Amgen Fremont Inc. PSMA antibodies and protein multimers
WO2006123576A1 (ja) * 2005-05-16 2006-11-23 National Institute Of Advanced Industrial Science And Technology 液体クロマトグラフィー用担体、該担体を充填したクロマトグラフィー用カラム、及び該カラムを用いた有機物の分離方法
JP2009509169A (ja) * 2005-09-19 2009-03-05 ザ・ジョンズ・ホプキンス・ユニバーシティ 前立腺癌のためのバイオマーカー
EP2164591B1 (de) * 2007-07-09 2013-05-08 GE Healthcare Bio-Sciences AB Verfahren zur herstellung eines biomoleküladsorptionsmittels
CN101279246B (zh) * 2007-12-28 2011-07-27 华侨大学 一种嗜硫性磁性复合微球的制备方法和用此复合微球分离免疫球蛋白g的方法
CN102360011A (zh) * 2011-08-16 2012-02-22 内蒙古科慧生物科技有限责任公司 总***特异性抗原(tpsa)定量测定试剂盒及其检测方法
CN102426245A (zh) * 2011-08-31 2012-04-25 内蒙古科慧生物科技有限责任公司 细胞角质蛋白19片段(cyfra21-1)定量测定试剂盒及其检测方法
CN104614519A (zh) * 2015-02-02 2015-05-13 东南大学 一种大豆过氧化物酶标记化学发光免疫检测试剂盒及使用方法和应用
CN108333358B (zh) * 2017-01-19 2020-05-01 深圳市新产业生物医学工程股份有限公司 一种免疫亲和纯化洗脱液的筛选方法
CA3050085A1 (en) 2017-01-20 2018-07-26 Juno Therapeutics Gmbh Cell surface conjugates and related cell compositions and methods
JP7284707B2 (ja) 2017-04-07 2023-05-31 ジュノー セラピューティクス インコーポレイテッド 前立腺特異的膜抗原（ｐｓｍａ）またはその改変型を発現する操作された細胞および関連方法
CN115950969B (zh) * 2022-11-08 2023-09-01 中国计量科学研究院 一种血清中游离***特异抗原的定值方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162504A (en) 1988-06-03 1992-11-10 Cytogen Corporation Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients
DK165090D0 (da) 1990-07-09 1990-07-09 Kem En Tec As Konglomererede partikler
CA2047073A1 (en) 1990-07-19 1992-01-20 William J. Leanza Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties
SE9002480D0 (sv) 1990-07-23 1990-07-23 Hans Lilja Assay of free and complexed prostate-specific antigen
DK130991D0 (da) 1991-07-04 1991-07-04 Immunodex K S Polymere konjugater
US6020208A (en) 1994-05-27 2000-02-01 Baylor College Of Medicine Systems for surface-enhanced affinity capture for desorption and detection of analytes
AU676582B2 (en) 1993-05-28 1997-03-13 Baylor College Of Medicine Method and apparatus for desorption and ionization of analytes
US5599677A (en) 1993-12-29 1997-02-04 Abbott Laboratories Immunoassays for prostate specific antigen
US5798448A (en) 1994-10-27 1998-08-25 Genentech, Inc. AL-1 neurotrophic factor antibodies
US5698402A (en) 1995-02-23 1997-12-16 Dianon Systems, Inc. Methods for diagnosing benign prostatic hyperplasia
US5837826A (en) 1995-02-27 1998-11-17 Regents Of The University Of Minnesota Protein adsorption by very dense porous zirconium oxide particles in expanded beds
US5654161A (en) 1995-05-12 1997-08-05 Chiron Diagnostics Corporation Method for diagnosing prostate cancer
US5861248A (en) 1996-03-29 1999-01-19 Urocor, Inc. Biomarkers for detection of prostate cancer
US6159462A (en) 1996-08-16 2000-12-12 Genentech, Inc. Uses of Wnt polypeptides
US5851984A (en) 1996-08-16 1998-12-22 Genentech, Inc. Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
IL121659A (en) 1996-10-25 2000-07-16 Bayer Ag Method for determining CPSA in a blood sample
US5856182A (en) 1996-11-18 1999-01-05 Beckman Coulter, Inc. Monoclonal antibodies specific for the PSA-ACT complex
NZ516848A (en) 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
US6171578B1 (en) 1999-04-14 2001-01-09 Diatide, Inc. Benzodiazepine derivatives for imaging thrombi
US6379550B1 (en) * 2000-07-24 2002-04-30 Health Research, Inc. Method for detecting PSA and its molecular forms using thiophilic gel

Also Published As

Publication number Publication date
EP1178317A1 (de) 2002-02-06
DE60107022D1 (de) 2004-12-16
EP1178317B1 (de) 2004-11-10
JP2002277469A (ja) 2002-09-25
DE60107022T2 (de) 2005-11-24
CA2353267A1 (en) 2002-01-24
US20020166814A1 (en) 2002-11-14
US6692643B2 (en) 2004-02-17

Similar Documents

Publication Publication Date Title
ATE282205T1 (de) Verfahren zur detektion von prostata-spezifischem membran-antigen in serum
DE69902676T2 (de) Assay unter verwendung von porositätsverminderung zur verhinderung von migration
FI860112A (fi) Menetelmä ja laite immunoanalyysejä varten
ATE221202T1 (de) Bestimmungsverfahren mit oligomerisierten rezeptoren
ATE530912T1 (de) Signalverbesserungsystem mit mehrfachen markierten mitteln
DE69938701D1 (de) Verfahren und vorrichtung zum nachweis von antikörpern
ATE268906T1 (de) Laterale durchflussvorrichtung mit teilchenförmigem träger
DK158682C (da) Fremgangsmaade og analysekit til paavisning af antigener og antistoffer.
DE68923605T2 (de) Immunodiagnostisches Verfahren zum Nachweis und zur Bestimmung von Euterentzündung.
DE60214155D1 (de) Verfahren zur beschleunigung und verstärkung der bindung von zielkomponenten an rezeptoren und vorrichtung dafür
DE59712595D1 (de) Homogene Nachweisverfahren zur Bestimmung von Subpopulationen eines Analyten
CN100395551C (zh) 基于阵列的生物分子分析方法
WO2002079783A3 (en) Method and device for testing for bence-jones protein
ATE434185T1 (de) Immunoassay für h. pylori in fäkalienproben mit hilfe von gattungsspezifischen antikörpern
WO2003052379A3 (en) Rapid immunoassay for rsv
RU2007140911A (ru) Способ выявления антигенов и антител в иммуноферментном анализе
ATE249047T1 (de) Verfahren zum spezifischen nachweis von glykosilierten proteinen
RU2004113367A (ru) Серологический анализ на neospora caninum
WO2002042416A3 (en) Immunoassay for fish identification
Liao et al. Highly sensitive immunosensor using a nanofluidic preconcentrator
ES2195728A1 (es) Metodo para la deteccion de antigenos de fasciola hepatica en heces basado en un test elisa-sandwich

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties